Literature DB >> 30129683

Selective Activation of Human Caseinolytic Protease P (ClpP).

Matthias Stahl1,2, Vadim S Korotkov1, Dóra Balogh1, Leonhard M Kick1, Malte Gersch1,3, Axel Pahl1,4, Pavel Kielkowski1, Klaus Richter1, Sabine Schneider1, Stephan A Sieber1.   

Abstract

Caseinolytic protease P (ClpP) is the proteolytic component of the ClpXP protein degradation complex. Eukaryotic ClpP was recently found to act within the mitochondria-specific unfolded protein response (UPRmt ). However, its detailed function and dedicated regulation remain largely unexplored. A small molecule (D9) acts as a potent and species-selective activator of human ClpP (hClpP) by mimicking the natural chaperone ClpX. Structure-activity relationship studies highlight the importance of a halogenated benzyl motif within D9 that interacts with a unique aromatic amino acid network in hClpP. Mutational and structural studies suggest that this YYW motif tightly controls hClpP activity and regulates substrate turnover by interaction with cognate ligands. This signature motif is unique to ClpP from higher organisms and does not exist in tested bacterial homologues, allowing a species-selective analysis. Thus, D9 is a versatile tool to analyze mechanistic features of hClpP.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  activation; crystallography; human ClpP; proteolysis

Mesh:

Substances:

Year:  2018        PMID: 30129683     DOI: 10.1002/anie.201808189

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  10 in total

Review 1.  Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic Potential.

Authors:  Heike Brötz-Oesterhelt; Andreas Vorbach
Journal:  Front Mol Biosci       Date:  2021-05-13

2.  Overexpression of PGC-1α influences the mitochondrial unfolded protein response (mtUPR) induced by MPP+ in human SH-SY5Y neuroblastoma cells.

Authors:  Yousheng Cai; Hui Shen; Huidan Weng; Yingqing Wang; Guoen Cai; Xiaochun Chen; Qinyong Ye
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.379

3.  Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues.

Authors:  Paul R Graves; Lucas J Aponte-Collazo; Emily M J Fennell; Adam C Graves; Andrew E Hale; Nedyalka Dicheva; Laura E Herring; Thomas S K Gilbert; Michael P East; Ian M McDonald; Matthew R Lockett; Hani Ashamalla; Nathaniel J Moorman; Donald S Karanewsky; Edwin J Iwanowicz; Ekhson Holmuhamedov; Lee M Graves
Journal:  ACS Chem Biol       Date:  2019-05-01       Impact factor: 4.634

Review 4.  ClpP Protease, a Promising Antimicrobial Target.

Authors:  Carlos Moreno-Cinos; Kenneth Goossens; Irene G Salado; Pieter Van Der Veken; Hans De Winter; Koen Augustyns
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

5.  Acyldepsipeptide Probes Facilitate Specific Detection of Caseinolytic Protease P Independent of Its Oligomeric and Activity State.

Authors:  Barbara Eyermann; Maximilian Meixner; Heike Brötz-Oesterhelt; Iris Antes; Stephan A Sieber
Journal:  Chembiochem       Date:  2020-01-07       Impact factor: 3.164

6.  Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpP.

Authors:  Emily M J Fennell; Lucas J Aponte-Collazo; Joshua D Wynn; Kristina Drizyte-Miller; Elisa Leung; Yoshimi Endo Greer; Paul R Graves; Andrew A Iwanowicz; Hani Ashamalla; Ekhson Holmuhamedov; Henk Lang; Donald S Karanewsky; Channing J Der; Walid A Houry; Stanley Lipkowitz; Edwin J Iwanowicz; Lee M Graves
Journal:  Pharmacol Res Perspect       Date:  2022-08

7.  Substrate Profiling of Mitochondrial Caseinolytic Protease P via a Site-Specific Photocrosslinking Approach.

Authors:  Tuan-Anh Nguyen; Thomas F Gronauer; Timon Nast-Kolb; Stephan A Sieber; Kathrin Lang
Journal:  Angew Chem Int Ed Engl       Date:  2022-01-14       Impact factor: 16.823

8.  Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development.

Authors:  Samuel Jacques; Almer M van der Sloot; Caroline C Huard; Jasmin Coulombe-Huntington; Sarah Tsao; Sylvain Tollis; Thierry Bertomeu; Elizabeth J Culp; Daniel Pallant; Michael A Cook; Eric Bonneil; Pierre Thibault; Gerard D Wright; Mike Tyers
Journal:  Genetics       Date:  2020-02-24       Impact factor: 4.562

9.  ClpP protease activation results from the reorganization of the electrostatic interaction networks at the entrance pores.

Authors:  Mark F Mabanglo; Elisa Leung; Siavash Vahidi; Thiago V Seraphim; Bryan T Eger; Steve Bryson; Vaibhav Bhandari; Jin Lin Zhou; Yu-Qian Mao; Kamran Rizzolo; Marim M Barghash; Jordan D Goodreid; Sadhna Phanse; Mohan Babu; Leandro R S Barbosa; Carlos H I Ramos; Robert A Batey; Lewis E Kay; Emil F Pai; Walid A Houry
Journal:  Commun Biol       Date:  2019-11-13

10.  Functional Characterisation of ClpP Mutations Conferring Resistance to Acyldepsipeptide Antibiotics in Firmicutes.

Authors:  Imran T Malik; Rebeca Pereira; Marie-Theres Vielberg; Christian Mayer; Jan Straetener; Dhana Thomy; Kirsten Famulla; Helena Castro; Peter Sass; Michael Groll; Heike Brötz-Oesterhelt
Journal:  Chembiochem       Date:  2020-04-09       Impact factor: 3.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.